This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n12http://localhost/temp/predkladatel/
n15http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n16http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n18http://bibframe.org/vocab/
n10http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15110%2F12%3A33152304%21RIV15-MSM-15110___/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n11http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61989592%3A15110%2F12%3A33152304%21RIV15-MSM-15110___
rdf:type
n16:Vysledek skos:Concept
dcterms:description
The Digital Ulcers Outcome (DUO) Registry was designed to describe the clinical and antibody characteristics, disease course and outcomes of patients with digital ulcers associated with systemic sclerosis (SSc). The DUO Registry is a European, prospective, multicentre, observational, registry of SSc patients with ongoing digital ulcers disease, irrespective of treatment regimen. Data collected included demographics, SSc duration, SSc subset, internal organ manifestations, autoantibodies, previous and ongoing interventions and complications related to didital ulcers. Up to 19 Novečmber 2010 a total of 2439 patients had enrolled into the registry. Most were classified as either limited cutaneous SSc (IcSSc; 52,2%) of diffuse cutaneous SSc (DcSSc; 36,9%).Digital ulcers developer earlier in patients with dcSSc compared with IcSSc. Almost all patients (95.7%) tested positive for antinuclear antibodies, 45,2% for anti-scleroderma-70 and 43,6% for anticentromere antibodies (ACA). The first digital ulcer in the anti-scleroderma-70-positive patient cohort occurred approximately 5 years earlier than the ACA-positive patient group. This study provedes data from a large cohort of SSc patients with a history of digital ulcers. The early occurrence and high frequency of digital ulcer complications are especially seen in patients with dcSSc and/or anti-scleroderma-70 antibodies. The Digital Ulcers Outcome (DUO) Registry was designed to describe the clinical and antibody characteristics, disease course and outcomes of patients with digital ulcers associated with systemic sclerosis (SSc). The DUO Registry is a European, prospective, multicentre, observational, registry of SSc patients with ongoing digital ulcers disease, irrespective of treatment regimen. Data collected included demographics, SSc duration, SSc subset, internal organ manifestations, autoantibodies, previous and ongoing interventions and complications related to didital ulcers. Up to 19 Novečmber 2010 a total of 2439 patients had enrolled into the registry. Most were classified as either limited cutaneous SSc (IcSSc; 52,2%) of diffuse cutaneous SSc (DcSSc; 36,9%).Digital ulcers developer earlier in patients with dcSSc compared with IcSSc. Almost all patients (95.7%) tested positive for antinuclear antibodies, 45,2% for anti-scleroderma-70 and 43,6% for anticentromere antibodies (ACA). The first digital ulcer in the anti-scleroderma-70-positive patient cohort occurred approximately 5 years earlier than the ACA-positive patient group. This study provedes data from a large cohort of SSc patients with a history of digital ulcers. The early occurrence and high frequency of digital ulcer complications are especially seen in patients with dcSSc and/or anti-scleroderma-70 antibodies.
dcterms:title
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry
skos:prefLabel
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry
skos:notation
RIV/61989592:15110/12:33152304!RIV15-MSM-15110___
n3:aktivita
n7:I
n3:aktivity
I
n3:cisloPeriodika
5
n3:dodaniDat
n11:2015
n3:domaciTvurceVysledku
n15:6386911
n3:druhVysledku
n4:J
n3:duvernostUdaju
n14:S
n3:entitaPredkladatele
n10:predkladatel
n3:idSjednocenehoVysledku
130017
n3:idVysledku
RIV/61989592:15110/12:33152304
n3:jazykVysledku
n5:eng
n3:klicovaSlova
DUO Registry; systemic sclerosis; digital ulcers
n3:klicoveSlovo
n17:DUO%20Registry n17:digital%20ulcers n17:systemic%20sclerosis
n3:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n3:kontrolniKodProRIV
[EBF29B9EE2C0]
n3:nazevZdroje
Annals of the Rheumatic Diseases
n3:obor
n9:FP
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
698
n3:rokUplatneniVysledku
n11:2012
n3:svazekPeriodika
71
n3:tvurceVysledku
Guillevin, Loic Krieg, Thomas Denton, Christopher Smržová, Andrea
s:issn
0003-4967
s:numberOfPages
4
n18:doi
10.1136/annrheumdis-2011-200631
n12:organizacniJednotka
15110